Abstract
The importance of medical professionals like clinical pharmacologists in the field of sport medicine lies in their expertise in doping and anti-doping. There is a need to identify the expertise globally and understand the pattern of research being done in this area. This helps for future collaborative and combined policies, irrespective of any borders. The purpose of this study was to conduct a scientometric examination of bibliographic facts linked to clinical pharmacology in doping and antidoping, and data from PubMed was retrieved between January 2012 and January 2021. This study looked at scientometric approaches such as frequency distribution, percentage analysis, relative growth rate and doubling time, and level of collaboration. During the research period, we acquired a total of 65 articles, and a maximum of 13 (20%) were contributed in the year 2021. The relative growth rate is declining, and the doubling time was increasing between 2014 and 2021. This will be the first scientometric analysis done on the topic to best of our knowledge, and this study will act as a document for further research on the topic.
Keywords: Scientometic, clinical pharmacology, doping, anti-doping, bibliometric, bibliographic facts.
Current Drug Therapy
Title:Analysis of Clinical Pharmacsology Research Publication in Doping and Anti-Doping: A Scientometric Study
Volume: 20 Issue: 2
Author(s): Vikas Katiyara, Hemasri Velmurugan, Himanchu Nirmal Chandu, Muthathal Subramanian, Pugazhenthan Thangaraju*, Sajitha Venkatesan and Eswaran Thangaraju
Affiliation:
- Department of Pharmacology, AIIMS, Raipur, Chhattisgarh, India
Keywords: Scientometic, clinical pharmacology, doping, anti-doping, bibliometric, bibliographic facts.
Abstract: The importance of medical professionals like clinical pharmacologists in the field of sport medicine lies in their expertise in doping and anti-doping. There is a need to identify the expertise globally and understand the pattern of research being done in this area. This helps for future collaborative and combined policies, irrespective of any borders. The purpose of this study was to conduct a scientometric examination of bibliographic facts linked to clinical pharmacology in doping and antidoping, and data from PubMed was retrieved between January 2012 and January 2021. This study looked at scientometric approaches such as frequency distribution, percentage analysis, relative growth rate and doubling time, and level of collaboration. During the research period, we acquired a total of 65 articles, and a maximum of 13 (20%) were contributed in the year 2021. The relative growth rate is declining, and the doubling time was increasing between 2014 and 2021. This will be the first scientometric analysis done on the topic to best of our knowledge, and this study will act as a document for further research on the topic.
Export Options
About this article
Cite this article as:
Katiyara Vikas, Velmurugan Hemasri, Chandu Nirmal Himanchu, Subramanian Muthathal, Thangaraju Pugazhenthan*, Venkatesan Sajitha and Thangaraju Eswaran, Analysis of Clinical Pharmacsology Research Publication in Doping and Anti-Doping: A Scientometric Study, Current Drug Therapy 2025; 20 (2) . https://dx.doi.org/10.2174/0115748855270231231123024158
DOI https://dx.doi.org/10.2174/0115748855270231231123024158 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
IgE-Mediated Disorders: Current Therapeutics and New Strategies Involving Synthetic Peptides
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Chlorella vulgaris: A Multifunctional Dietary Supplement with Diverse Medicinal Properties
Current Pharmaceutical Design Small Molecule Immunosuppressive Agents in Experimental and Clinical Transplantation
Current Drug Targets - Cardiovascular & Hematological Disorders Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
Current Neuropharmacology The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Current Topics in Medicinal Chemistry Aceruloplasminemia
Current Drug Targets Targeting MAPK Signalling: Prometheus Fire or Pandoras Box?
Current Pharmaceutical Design Safety Considerations of the Use of Second Generation Antipsychotics in the Treatment of Major Depression: Extrapyramidal and Metabolic Side Effects
Current Drug Safety Overlapping Molecular Signatures in Parkinson's Patient Leukocytes Before and After Treatment and in Mouse Model Brain Regions
CNS & Neurological Disorders - Drug Targets Pyrimidine Derivatives as Potential Agents Acting on Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Treating COPD in Older and Oldest Old Patients
Current Pharmaceutical Design Liver Disease and Hepatocellular Carcinoma in Alcoholics: The Role of Anticraving Therapy
Current Drug Targets Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease
Current Drug Metabolism Medicinal Prospects of Targeting Tyrosinase: A Feature Review
Current Medicinal Chemistry Inflammatory Process in Alzheimer’s and Parkinson's Diseases: Central Role of Cytokines
Current Pharmaceutical Design Effective Biomarkers for Proof-of-Concept
Current Medical Imaging The Application of Proteomics in Neurology
Current Proteomics Pathogenic Role of Serine Protease HtrA2/Omi in Neurodegenerative Diseases
Current Protein & Peptide Science Pharmacotherapy for Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Induction of Haemolysis and DNA Fragmentation in a Normal and Malarial-Infected Blood by Commonly - used Antimalarial Drugs in the North-Western Region of Nigeria
Drug Metabolism Letters